FDA inspection
Symbiosis Pharmaceutical Services Limited: FDA inspection ending Jan 31, 2025
FDA inspection 1266061 · No Action Indicated (NAI) · Stirling
Key facts
| Inspection ID | 1266061 |
|---|---|
| Firm | Symbiosis Pharmaceutical Services Limited |
| FEI number | 3009864467 |
| Address | Unit 10, Scion House; Stirling University Innovation Park |
| City | Stirling |
| Country | United Kingdom |
| Fiscal year | 2025 |
| Inspection end date | Jan 31, 2025 |
| Classification | No Action Indicated (NAI) |
| Project area | Human Cellular, Tissue, and Gene Therapies |
| Product type | Biologics |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data